Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Pfizer (PFE) Tops Q2 EPS by 21c, Beats on Revenue; Offers FY25 EPS Guidance
August 5, 2025 6:47 AM EDTPfizer (NYSE: PFE) reported Q2 EPS of $0.78, $0.21 better than the analyst estimate of $0.57. Revenue for the quarter came in at $14.7 billion versus the consensus estimate of $13.47 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.90-$3.10, versus the consensus of $3.01.
For earnings history and earnings-related data on Pfizer (PFE) click here.
... More